Home / Existing Clinic Growth
Many clinic revenue problems are not treatment problems. They are positioning, supplier, training or marketing problems, and our team has seen each of them across hundreds of clinic launches.
Talk to the ACG TeamFree 30-minute call · No obligation · No generic report
You're seeing patients and covering costs, but growth has stalled. Volume looks fine; the economics underneath don't match what they should.
A competitor opened nearby and your first instinct was to lower prices. That's a signal: patients don't yet choose your clinic by name. ACG works on the positioning, not just the service menu.
Clinical quality is fine, but the front office loses patients in the consultation, turnover hurts consistency, and training hasn't kept up with your services. The ceiling is people, not patients.
If any of these sounds familiar, the 30-minute call is where we start.
Four areas, each a gap that costs existing clinics revenue: training, supplier access, operations and marketing. You get specific, prioritized findings, not a generic report.
The gap between a strong clinical offering and a thriving practice is often a training gap. ACG trains your staff on the protocols your Medical Director approves, on the cash-pay consultation and on front and back office workflow, from intake to follow-up. See clinic staff training for the full program.
A skilled nurse who cannot explain a treatment plan in terms that build confidence costs more in lost consultations than any equipment purchase.
ACG clients get pre-negotiated pricing on clinical supplies, materials and equipment that is unavailable outside the network, a difference that compounds every month. Introductions are made at no additional charge through our clinic supplier network.
ACG reviews your patient flow, daily systems, staff roles and consultation process: how your team moves a patient from first contact to commitment. Many clinics have at least one efficiency gap costing revenue they cannot see from the inside.
Our clinic marketing audit measures five numbers: cost per lead, booking rate from lead to consultation, show rate, consultation-to-patient conversion and cost per acquired patient. Many clinics find at least one running well below where it should.
Many regenerative health categories face ad platform restrictions; Google's cell therapy ad policy, for one, covers stem cell therapy and PRP. A clinic built only on paid ads is one policy change from a patient acquisition problem, so ACG plans the organic foundation first. Marketing execution is a separate engagement.
Before ACG recommends anything, we review your operation: supplier costs against our network's rates, marketing against category benchmarks, staff training gaps and operational efficiency. You get specific, prioritized findings, and the scope of the engagement follows what we find.
"If we don't find at least three specific, actionable opportunities, we'll tell you that directly."
Which services underperform, which carry the clinic, and where the ceiling is.
Where your current costs differ from what ACG clients pay.
Why prospects aren't committing, and what to change in the consultation.
What the team does well, and where training closes the gap.
Cost per lead, booking and show rates: where the budget works and where it's wasted.
Services your existing patients would respond to and your clinic can support.
Your patient base, the trust you have built and your infrastructure are already in place. What's missing is the right service, supplier access, training and a compliance structure, and ACG plans all four around your patients and your market. Planning another location instead? We can help you open a second wellness clinic.
"ACG doesn't produce generic reports. The assessment covered our specific operation, our supplier costs, our marketing metrics, our team's conversion performance. Specific findings. Prioritized."
FTC Disclaimer: Results not typical. Individual outcomes vary.
"The supplier access alone changed our economics. We had no idea how much we were leaving on the table with our previous vendors. The introductions happened within the first week."
FTC Disclaimer: Results not typical. Individual outcomes vary.
"We were busy and thought we didn't need outside help. The assessment revealed a consultation process issue we hadn't seen from the inside. Conversion improved significantly in the first month."
FTC Disclaimer: Results not typical. Individual outcomes vary.
What existing clinic owners ask before signing on. Anything else, ask on the strategy call.
View All FAQs
Talk with Grayson Miller about where your clinic stands: supplier costs, your team's consultations, your marketing numbers and what to add next. No pitch. No obligation.
ACG is a consulting and advisory firm, not a medical practice; an independent, state-licensed Medical Director directs all clinical care. Results are not guarantees of income. Individual outcomes vary.
Knowing the rules is the foundation of every clinic we help launch.
You own and run the business. An independent, state-licensed Medical Director makes every clinical, prescribing and treatment decision, structured for your state's Corporate Practice of Medicine laws. We connect you to a vetted network; you retain your own provider.
PRP, peptides, GLP-1 medications and cellular products each carry federal and state rules, and not every product or use is FDA-approved. Exosomes for therapeutic use are not FDA-approved at all, and we steer you away from them. Your menu and marketing are built to hold up to FDA, FTC and state medical board scrutiny.
We show real ranges and never promise an income or a clinical outcome. What you earn depends on your market, your capital and your execution.
Altos Consulting Group is a business consulting and advisory firm, not a medical practice, and does not provide, prescribe or sell any drug, biologic, device or therapy. The FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease; clinic owners are responsible for the compliance of every product, therapy and claim. See the full regulatory notice below.